News

A new therapy currently undergoing clinical studies offers hope to macular degeneration patients. Pazonpanib which has been used as an oral treatment for renal cell carcinoma can also be administer...

After undergoing a massive expansion, the Kellogg Eye Center located at the University of Michigan in Ann Arbor is having a dedication ceremony on April 23, 2010. The expanded facility includes a r...

A study published in the April 2010 issue of the Federation of American Societies for Experimental Biology (FASEB) Journal details the results of using nucleic acid nanoparticles to restore the vis...

A vitamin E packed contact lens has the potential of preserving the vision of people being treated for glaucoma. While the contact lens can't repair damage that has been done, it can prevent any fu...

While men and women have many health differences, one difference that is probably not widely known is that women are more susceptible to eye disease and other eye conditions than men. Eye diseases ...

People who are at the highest risk of developing glaucoma may benefit from early treatment of ocular hypertension. Ocular hypertension is high pressure within the eye and is a leading risk factor f...

Renowned ophthalmologist, Dr. Arnall Patz, has passed away at the age of 89. Dr. Patz's groundbreaking research led to the discovery that high doses of oxygen administered to premature infants coul...

The Food and Drug Administration (FDA) has given Acucela and Otsuka the Fast Track designation for their new oral medication intended to treat dry age-related macular degeneration (AMD).

Researchers have found a relationship between anti-depressant use and an increased risk of developing cataracts. A recent study found a statistical relationship between a diagnosis of cataracts? or...